Holen Sie sich die Stockscreener-App
288.47
3.10%
8.68
Schlusskurs vom Vortag:
$279.79
Offen:
$279.69
24-Stunden-Volumen:
620.99K
Relative Volume:
1.41
Marktkapitalisierung:
$11.30B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$42.23M
KGV:
272.14
EPS:
1.06
Netto-Cashflow:
$150.33M
1W Leistung:
+3.00%
1M Leistung:
+15.85%
6M Leistung:
+6.69%
1J Leistung:
+19.95%
1-Tages-Spanne:
$279.69
$293.18
1-Wochen-Bereich:
$276.01
$293.18
52-Wochen-Spanne:
$221.26
$310.00
Penumbra Inc Stock (PEN) Company Profile
Firmenname
Penumbra Inc
Sektor
Branche
Telefon
(510) 995-2486
Adresse
ONE PENUMBRA PLACE, ALAMEDA, CA
Vergleichen Sie PEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
288.47 | 10.96B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | Wells Fargo | Underweight |
| 2025-10-08 | Hochstufung | Needham | Hold → Buy |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-03-14 | Eingeleitet | BofA Securities | Buy |
| 2025-01-21 | Eingeleitet | UBS | Buy |
| 2024-12-17 | Eingeleitet | Oppenheimer | Outperform |
| 2024-12-11 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | Eingeleitet | Stifel | Buy |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-31 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-07-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-09-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-29 | Herabstufung | Needham | Buy → Hold |
| 2023-01-30 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-09 | Hochstufung | Needham | Hold → Buy |
| 2022-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-04-19 | Eingeleitet | Deutsche Bank | Buy |
| 2022-03-08 | Eingeleitet | Needham | Hold |
| 2021-09-16 | Eingeleitet | Truist | Buy |
| 2021-06-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-07 | Fortgesetzt | Canaccord Genuity | Buy |
| 2020-09-29 | Eingeleitet | BTIG Research | Buy |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-06-13 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-05-21 | Eingeleitet | William Blair | Outperform |
| 2018-10-29 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-10-08 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-02-21 | Eingeleitet | William Blair | Outperform |
| 2018-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-13 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Penumbra Inc Aktie (PEN) Neueste Nachrichten
Those Who Invested in Penumbra (NYSE:PEN) Three Years Ago Are up 47% - 富途牛牛
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know - Finviz
[144] Penumbra Inc SEC Filing - Stock Titan
Shareholder Bose Family Holdings II LLC Files To Sell 30,000 Of Penumbra Inc [PEN] - TradingView
Can Penumbra Inc. stock reach $200 price targetGold Moves & Long-Term Growth Portfolio Plans - newser.com
What Wall Street predicts for Penumbra Inc. stock priceDollar Strength & Reliable Intraday Trade Alerts - newser.com
How supply shortages influence Penumbra Inc. stock2025 Price Targets & Scalable Portfolio Growth Ideas - newser.com
Why Penumbra Inc. (0P8) stock remains top ratedWeekly Market Summary & Momentum Based Trading Ideas - newser.com
How Penumbra became a $1 billion leader in blood clot removal devices - The Business Journals
Is Penumbra Inc. stock trading at attractive multiplesEntry Point & Consistent Growth Equity Picks - newser.com
Why Penumbra Inc. stock fits value portfoliosEntry Point & Verified Technical Trade Signals - newser.com
Is Penumbra Inc. stock a top hedge fund pickJuly 2025 Closing Moves & Weekly Market Pulse Alerts - newser.com
Is Penumbra Inc. stock attractive for ETFsEarnings Summary Report & High Yield Equity Trading Tips - newser.com
Should I hold or sell Penumbra Inc. stock in 2025Quarterly Profit Report & Daily Growth Stock Tips - newser.com
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference - Lelezard
Penumbra Inc. (PEN) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Why retail traders accumulate Penumbra Inc. (0P8) stockMarket Growth Summary & Verified Entry Point Signals - newser.com
Custom watchlist performance reports with Penumbra Inc.Dip Buying & Long-Term Safe Investment Ideas - newser.com
Does Penumbra Inc. stock trade at a discount to peersTrade Volume Summary & Technical Pattern Based Signals - newser.com
United States Interventional Neurology Devices Market 2025: - openPR.com
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term - sharewise.com
Is Penumbra Inc. stock attractive for retirement portfoliosJuly 2025 Institutional & Weekly Breakout Watchlists - newser.com
[Form 4] Penumbra Inc Insider Trading Activity - Stock Titan
CFO Yuen Surrenders 691 Of Penumbra Inc [PEN] - TradingView
Finanzdaten der Penumbra Inc-Aktie (PEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):